519 related articles for article (PubMed ID: 28705439)
21. Activation of nociceptin/orphanin FQ-NOP receptor system inhibits tyrosine hydroxylase phosphorylation, dopamine synthesis, and dopamine D(1) receptor signaling in rat nucleus accumbens and dorsal striatum.
Olianas MC; Dedoni S; Boi M; Onali P
J Neurochem; 2008 Oct; 107(2):544-56. PubMed ID: 18717817
[TBL] [Abstract][Full Text] [Related]
22. Quantitative study of [(pF)Phe4,Arg14,Lys15]nociceptin/orphanin FQ-NH2 (UFP-102) at NOP receptors in rat periaqueductal gray slices.
Kuo CJ; Liao YY; Guerrini R; Calo' G; Chiou LC
Eur J Pharmacol; 2008 Jan; 579(1-3):110-5. PubMed ID: 17976580
[TBL] [Abstract][Full Text] [Related]
23. Role of nociceptin/orphanin FQ and NOP receptors in the response to acute and repeated restraint stress in rats.
Delaney G; Dawe KL; Hogan R; Hunjan T; Roper J; Hazell G; Lolait SJ; Fulford AJ
J Neuroendocrinol; 2012 Dec; 24(12):1527-41. PubMed ID: 22835008
[TBL] [Abstract][Full Text] [Related]
24. Nociceptin and the nociceptin receptor in learning and memory.
Andero R
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Oct; 62():45-50. PubMed ID: 25724763
[TBL] [Abstract][Full Text] [Related]
25. Modification of anxiety-like behaviors by nociceptin/orphanin FQ (N/OFQ) and time-dependent changes in N/OFQ-NOP gene expression following ethanol withdrawal.
Aujla H; Cannarsa R; Romualdi P; Ciccocioppo R; Martin-Fardon R; Weiss F
Addict Biol; 2013 May; 18(3):467-79. PubMed ID: 22804785
[TBL] [Abstract][Full Text] [Related]
26. Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity.
Guerrini R; Carra' G; Calo' G; Trapella C; Marzola E; Rizzi D; Regoli D; Salvadori S
J Pept Res; 2004 Jun; 63(6):477-84. PubMed ID: 15175020
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex.
Mela F; Marti M; Ulazzi L; Vaccari E; Zucchini S; Trapella C; Salvadori S; Beani L; Bianchi C; Morari M
Eur J Neurosci; 2004 Mar; 19(5):1317-24. PubMed ID: 15016089
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor.
Rizzi A; Spagnolo B; Wainford RD; Fischetti C; Guerrini R; Marzola G; Baldisserotto A; Salvadori S; Regoli D; Kapusta DR; Calo G
Peptides; 2007 Jun; 28(6):1240-51. PubMed ID: 17532097
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological characterization of nociceptin/orphanin FQ receptors, a novel opioid receptor family, in the midbrain periaqueductal gray.
Chiou LC; Fan SH; Chuang KC; Liao YY; Lee SZ
Ann N Y Acad Sci; 2004 Oct; 1025():398-403. PubMed ID: 15542742
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological characterization of the nociceptin/orphanin FQ receptor on ethanol-mediated motivational effects in infant and adolescent rats.
Miranda-Morales RS; Pautassi RM
Behav Brain Res; 2016 Feb; 298(Pt A):88-96. PubMed ID: 25907741
[TBL] [Abstract][Full Text] [Related]
31. Functional selectivity of nociceptin/orphanin FQ peptide receptor partial agonists on cardiovascular and renal function.
Kapusta DR; Burmeister MA; Calo' G; Guerrini R; Gottlieb HB; Kenigs VA
J Pharmacol Exp Ther; 2005 Aug; 314(2):643-51. PubMed ID: 15855356
[TBL] [Abstract][Full Text] [Related]
32. Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD.
Andero R; Brothers SP; Jovanovic T; Chen YT; Salah-Uddin H; Cameron M; Bannister TD; Almli L; Stevens JS; Bradley B; Binder EB; Wahlestedt C; Ressler KJ
Sci Transl Med; 2013 Jun; 5(188):188ra73. PubMed ID: 23740899
[TBL] [Abstract][Full Text] [Related]
33. The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions.
Broccardo M; Linari G; Guerrini R; Agostini S; Petrella C; Improta G
Peptides; 2005 Sep; 26(9):1590-7. PubMed ID: 16112397
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells.
Wright KE; McDonald J; Barnes TA; Rowbotham DJ; Guerrini R; Calo' G; Lambert DG
Neurosci Lett; 2003 Aug; 346(3):145-8. PubMed ID: 12853105
[TBL] [Abstract][Full Text] [Related]
35. Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.
Donica CL; Awwad HO; Thakker DR; Standifer KM
Mol Pharmacol; 2013 May; 83(5):907-18. PubMed ID: 23395957
[TBL] [Abstract][Full Text] [Related]
36. The Nociceptin/Orphanin FQ System and the Regulation of Memory.
Moulédous L
Handb Exp Pharmacol; 2019; 254():259-278. PubMed ID: 30430261
[TBL] [Abstract][Full Text] [Related]
37. Mu-opioid peptide (MOP) and nociceptin/orphanin FQ peptide (NOP) receptor activation both contribute to the discriminative stimulus properties of cebranopadol in the rat.
Tzschentke TM; Rutten K
Neuropharmacology; 2018 Feb; 129():100-108. PubMed ID: 29155273
[TBL] [Abstract][Full Text] [Related]
38. Panicolytic-like effects caused by substantia nigra pars reticulata pretreatment with low doses of endomorphin-1 and high doses of CTOP or the NOP receptors antagonist JTC-801 in male Rattus norvegicus.
da Silva JA; Biagioni AF; Almada RC; de Freitas RL; Coimbra NC
Psychopharmacology (Berl); 2017 Oct; 234(20):3009-3025. PubMed ID: 28856406
[TBL] [Abstract][Full Text] [Related]
39. Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands.
Asth L; Ruzza C; Malfacini D; Medeiros I; Guerrini R; Zaveri NT; Gavioli EC; Calo' G
Neuropharmacology; 2016 Jun; 105():434-442. PubMed ID: 26867504
[TBL] [Abstract][Full Text] [Related]
40. Fear expression is reduced after acute and repeated nociceptin/orphanin FQ (NOP) receptor antagonism in rats: therapeutic implications for traumatic stress exposure.
Taylor RM; Jeong IH; May MD; Bergman EM; Capaldi VF; Moore NLT; Matson LM; Lowery-Gionta EG
Psychopharmacology (Berl); 2020 Oct; 237(10):2943-2958. PubMed ID: 32588078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
